Like the egg-based vaccine production process, producing a vaccine under cGMP conditions using mammalian cells can be a lengthy process, taking a minimum of six to 12 months.
Melissa M. Rosness
Advertisement
Articles by Melissa M. Rosness
Advertisement
Latest Updated Articles
Plasmid DNA–Based Vaccines: Combating Infectious DiseasesAugust 2nd 2007
Advertisement
Advertisement
Trending on BioPharm International
1
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
2
Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals
3
Shift to In Vivo CAR T Will Reshape Facility Design, Says Arcadis’ Emily Heffernan
4
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
5